Document is current
Any future updates will be listed below
-
Authors
Daassi, Dhouha https://orcid.org/0000-0001-9877-2452
Mahoney, Kathleen M. https://orcid.org/0000-0002-3869-6803
Freeman, Gordon J. https://orcid.org/0000-0002-7210-5616
- License Information
-
More Information
Article History
Accepted: 6 December 2019
First Online: 21 January 2020
Competing interests
: G.J.F. has patents or pending royalties on the PD1–PDL1 pathway from Roche, Merck MSD, Bristol-Myers-Squibb, Merck KGA, Boehringer-Ingelheim, AstraZeneca, Dako, Leica, Mayo Clinic and Novartis. G.J.F. has served on advisory boards for Roche, Bristol-Myers-Squibb, Xios, Origimed, Triursus, iTeos and NextPoint. The other authors declare no competing interests.
